For the best analysis and treatment of your dry eyes please consult your optometrist or ophthalmologist. Many treatments start with a test to evaluate the actual severity of your dry eye condition. Drops or punctual plugs are often a first method of treatment. Other options include eye health vitamins and supplements to create a healthier eye. There are some prescription medications now available such as Restasis®. RESTASIS® Ophthalmic Emulsion is a prescription eye drop indicated to increase tear production which may be reduced by inflammation on the eye surface in patients with dry eye.
Over the counter eye drop for dry eye such are usually the first place dry eye patients start their quest for relief. Although these drops can provide some relief they typically do not solve the problem long-term. There are some excellent drops on the market that can provide some initial relief and are worth a try.
Evaporative Dry Eye is caused by blockages in the Meibomian glands, which create the lipid (oil) layer of the tear film and are located in your eyelids. This condition of obstructed glands is also known as Meibomian Gland Dysfunction. When the glands aren’t working as they should, you don’t have enough tear film oil. And your tears – which lubricate your eyes and keep them comfortable – evaporate too quickly. An insufficient oil layer can cause your tears to evaporate 4x – 6x faster.
Dry eye syndrome is a disease stems from a deficiency in the oily lipid layer of the eye’s natural tear film. The oily lipids serve as a protective layer so that the aqueous (water) layer of the eye’s tear film does not evaporate.
LipiFlow®, is intended to treat patients with blocked meibomian glands, called meibomian gland dysfunction, by unblocking the glands and allowing them to resume the secretion of oily lipids needed for a healthy tear film.
Dry eye disease affects more than 100 million people worldwide. Of those, 65 percent suffer from Evaporative Dry Eye.
These symptoms can hinder people’s daily activities such as reading, using the computer, wearing contact lenses and being outdoors on windy days. Many dry eye patients complain those symptoms worsen throughout the day.
Many eye care practices are pleased to introduce the new LipiFlow treatment to help those patients who are very frustrated with this chronic disease and all of the ways it negatively impacts their lives. In effect, LipiFlow helps the meibomian glands resume their natural function and many patients note symptom relief.
Historically, common therapies aimed at dry eye symptom relief included using warm compresses, over- the-counter wetting drops and ointments, and prescription drugs. Alternatively, the new LipiFlow treatment addresses the root cause of evaporative dry eye by unblocking the meibomian glands that secrete oily lipids. In controlled clinical studies of patients who received a single LipiFlow treatment, the average meibomian gland score at 4 weeks increased by two to three times over the baseline condition, which reflects improvement in the number of glands secreting and secretion quality. Additionally, at four weeks after the LipiFlow treatment, 79% of patients reported improvement in dry eye symptoms.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Sign Up Your Practice Today!